Editorial · Independent digest
About Doctor PT-141
An independent research console that reads the published PT-141 record straight — the mechanism, the trials, the label, and the tolerability data — and cites every clinical figure to source.
What this site is
Doctor PT-141 is an independent editorial project that publishes summaries of the peer-reviewed research literature and the approved label on PT-141 (bremelanotide). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site is built as a trust-and-evidence console: a place where the central mechanism, the RECONNECT trials, the FDA label figures, and the documented tolerability record are laid out plainly and cited, so a reader can see at a glance how strong — and how bounded — each claim is.
What 'Doctor' means here
The word 'Doctor' in the domain name is editorial framing, not a claim about services. It signals the register we aim for — careful, reference-grade, verifiable — the way a trustworthy medical-information source reads. It does not mean this site diagnoses, treats, prescribes, or consults. There are no doctors, pharmacists, or clinical staff behind this page, and no prescription, treatment, or consultation is offered here. PT-141 is a prescription drug for its approved indication; decisions about it belong with a qualified clinician, not a website.
How we handle evidence
Every quantitative clinical claim on this site is tied to a source in the references. We mark the difference between approved and off-label use, between human trials and animal models, and between cited evidence and unverified community reports. Where the evidence is strong — the two Phase 3 RECONNECT trials, the 52-week extension, the fMRI mechanism study — we say so. Where it is modest, disputed, or early-phase — the small effect sizes, the 2023 Expression of Concern on a 2008 study, the investigational male data — we say that too. The honest record includes its own limitations, and we keep those in plain view rather than smoothing them over.